Date	Period	Revenue/Estimate	Earnings Call
Feb 7, 2025	2025/Q1	18.000M / --	--
Aug 9, 2024	2024/Q3	18.000M / --	--
Feb 9, 2024	2024/Q1	18.000M / --	--
Aug 14, 2023	2023/Q3	17.000M / --	--
Feb 10, 2023	2023/Q1	17.000M / --	--

DatePeriodRevenue/EstimateEarnings Call

Feb 7, 20252025/Q118.000M / ----

Aug 9, 20242024/Q318.000M / ----

Feb 9, 20242024/Q118.000M / ----

Aug 14, 20232023/Q317.000M / ----

Feb 10, 20232023/Q117.000M / ----

Unlock Free Earnings Estimates

Open Account

Kringle Pharma Earnings Reports

Kringle Pharma: Responses to questions received in preparation for the announcement of financial results for the first quarter of the fiscal year ending September 2025

Feb 7 01:45 ET

Kringle Pharma: Financial results for the first quarter of the fiscal year ending September 2025 (financial results briefing materials)

Feb 7 01:45 ET

Kringle Pharma: Summary of financial results for the 1st quarter of the fiscal year ending September 2025 [Japanese GAAP] (unconsolidated)

Feb 7 01:40 ET

Kringle Pharma: Extraordinary Report

Dec 23, 2024 00:32 ET

Top JP Stock Gainers

Symbol Price % Chg

AI Fusion Capital Group

254A

1540 +24.19%